Skip to main content
Erschienen in: Clinical Research in Cardiology 10/2013

01.10.2013 | Original Paper

Clinical characteristics, morbidity, and prognostic value of concomitant coronary artery disease in idiopathic dilated cardiomyopathy

verfasst von: Lutz Frankenstein, Henrik Hees, Tobias Taeger, Hanna Froehlich, Andreas Dösch, Rita Cebola, Christian Zugck, Hugo A. Katus

Erschienen in: Clinical Research in Cardiology | Ausgabe 10/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Patients with idiopathic dilated cardiomyopathy (dCMP) might present coronary artery disease (CAD) concomitant to dCMP and prognostic differences between ischemic heart disease and non-ischemic cardiomyopathy have been described. Clinical characteristics and prognostic implications of concomitant CAD in patients with dCMP are largely unknown.

Methods

A total of 1,263 patients with chronic systolic dysfunction from dCMP—of these 67.1 % (n = 847; 72.3 % men) without and 32.9 % (n = 416; 80.8 % men) with concomitant CAD were included and baseline clinical characteristics noted. They were followed prospectively for 36.3 (20.8–65.0) months, representing 5,168 patient-years. All-cause mortality was the primary endpoint; and decompensation requiring hospitalisation as well as the combined endpoint thereof were secondary endpoints.

Results

Independent significant predictors of CAD were smoking status (current smoker: OR 2.68, 95 % CI 1.61–4.46; p < 0.001; past smoker: OR 2.52, 95 % CI 1.40–4.52; p < 0.005; each vs. non-smoker), presence of dyslipidemia (OR 3.46, 95 % CI 2.23–5.35; p < 0.001), age (OR 1.06, 95 % CI 1.04–1.08; p < 0.001), and female sex (OR 0.49, 95 % CI 0.29–0.81; p = 0.005). The presence of CAD was not a significant predictor of all-cause mortality (adjusted HR 0.74, 95 % CI 0.36–1.54; p = 0.42), morbidity (adjusted HR 1.48, 95 % CI 0.55–3.99; p = 0.44), or the combined endpoint (HR 0.65, 95 % CI 0.24–1.78; p = 0.40).

Conclusion

Concomitant CAD is common in patients with dCMP. Clinical predictors of its presence are largely coincident with classic risk factors in the general population. The presence of concomitant CAD appears not to be associated with adverse prognosis (morbidity or mortality) in patients with dCMP.
Literatur
1.
Zurück zum Zitat Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kuhl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A (2008) Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29:270–276PubMedCrossRef Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kuhl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A (2008) Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29:270–276PubMedCrossRef
2.
Zurück zum Zitat Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113:1807–1816PubMedCrossRef Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113:1807–1816PubMedCrossRef
3.
Zurück zum Zitat Esser S, Gelbrich G, Brockmeyer N, Goehler A, Schadendorf D, Erbel R, Neumann T, Reinsch N (2013) Prevalence of cardiovascular diseases in HIV-infected outpatients: results from a prospective, multicenter cohort study. Clin Res Cardiol 102:203–213PubMedCrossRef Esser S, Gelbrich G, Brockmeyer N, Goehler A, Schadendorf D, Erbel R, Neumann T, Reinsch N (2013) Prevalence of cardiovascular diseases in HIV-infected outpatients: results from a prospective, multicenter cohort study. Clin Res Cardiol 102:203–213PubMedCrossRef
4.
Zurück zum Zitat Angelini A, Boffa GM, Livi U, Barchitta A, Casarotto D, Thiene G (1999) Discordance between pre and post cardiac transplant diagnosis: implications for pre- and postoperative decision making. Cardiovasc Pathol 8:17–23PubMedCrossRef Angelini A, Boffa GM, Livi U, Barchitta A, Casarotto D, Thiene G (1999) Discordance between pre and post cardiac transplant diagnosis: implications for pre- and postoperative decision making. Cardiovasc Pathol 8:17–23PubMedCrossRef
5.
Zurück zum Zitat Bortman G, Sellanes M, Odell DS, Ring WS, Olivari MT (1994) Discrepancy between pre- and post-transplant diagnosis of end-stage dilated cardiomyopathy. Am J Cardiol 74:921–924PubMedCrossRef Bortman G, Sellanes M, Odell DS, Ring WS, Olivari MT (1994) Discrepancy between pre- and post-transplant diagnosis of end-stage dilated cardiomyopathy. Am J Cardiol 74:921–924PubMedCrossRef
6.
Zurück zum Zitat Repetto A, Dal Bello B, Pasotti M, Agozzino M, Vigano M, Klersy C, Tavazzi L, Arbustini E (2005) Coronary atherosclerosis in end-stage idiopathic dilated cardiomyopathy: an innocent bystander? Eur Heart J 26:1519–1527PubMedCrossRef Repetto A, Dal Bello B, Pasotti M, Agozzino M, Vigano M, Klersy C, Tavazzi L, Arbustini E (2005) Coronary atherosclerosis in end-stage idiopathic dilated cardiomyopathy: an innocent bystander? Eur Heart J 26:1519–1527PubMedCrossRef
7.
Zurück zum Zitat Waller TA, Hiser WL, Capehart JE, Roberts WC (1998) Comparison of clinical and morphologic cardiac findings in patients having cardiac transplantation for ischemic cardiomyopathy, idiopathic dilated cardiomyopathy, and dilated hypertrophic cardiomyopathy. Am J Cardiol 81:884–894PubMedCrossRef Waller TA, Hiser WL, Capehart JE, Roberts WC (1998) Comparison of clinical and morphologic cardiac findings in patients having cardiac transplantation for ischemic cardiomyopathy, idiopathic dilated cardiomyopathy, and dilated hypertrophic cardiomyopathy. Am J Cardiol 81:884–894PubMedCrossRef
8.
Zurück zum Zitat McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, Pennell DJ (2003) Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108:54–59PubMedCrossRef McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, Pennell DJ (2003) Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108:54–59PubMedCrossRef
9.
Zurück zum Zitat Hedrich O, Jacob M, Hauptman PJ (2004) Progression of coronary artery disease in non-ischemic dilated cardiomyopathy. Coron Artery Dis 15:291–297PubMedCrossRef Hedrich O, Jacob M, Hauptman PJ (2004) Progression of coronary artery disease in non-ischemic dilated cardiomyopathy. Coron Artery Dis 15:291–297PubMedCrossRef
10.
Zurück zum Zitat White BM, Mehta R, Binkley PF, Leier CV (2009) Latent development of occlusive coronary atherosclerosis as a cause of decompensation of non-ischemic dilated cardiomyopathy. Cardiology 112:69–73PubMedCrossRef White BM, Mehta R, Binkley PF, Leier CV (2009) Latent development of occlusive coronary atherosclerosis as a cause of decompensation of non-ischemic dilated cardiomyopathy. Cardiology 112:69–73PubMedCrossRef
11.
Zurück zum Zitat Adams KF Jr, Dunlap SH, Sueta CA, Clarke SW, Patterson JH, Blauwet MB, Jensen LR, Tomasko L, Koch G (1996) Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol 28:1781–1788PubMedCrossRef Adams KF Jr, Dunlap SH, Sueta CA, Clarke SW, Patterson JH, Blauwet MB, Jensen LR, Tomasko L, Koch G (1996) Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol 28:1781–1788PubMedCrossRef
12.
Zurück zum Zitat Ghali JK, Krause-Steinrauf HJ, Adams KF, Khan SS, Rosenberg YD, Yancy CW, Young JB, Goldman S, Peberdy MA, Lindenfeld J (2003) Gender differences in advanced heart failure: insights from the BEST study. J Am Coll Cardiol 42:2128–2134PubMedCrossRef Ghali JK, Krause-Steinrauf HJ, Adams KF, Khan SS, Rosenberg YD, Yancy CW, Young JB, Goldman S, Peberdy MA, Lindenfeld J (2003) Gender differences in advanced heart failure: insights from the BEST study. J Am Coll Cardiol 42:2128–2134PubMedCrossRef
13.
Zurück zum Zitat Bart BA, Shaw LK, McCants CB Jr, Fortin DF, Lee KL, Califf RM, O’Connor CM (1997) Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol 30:1002–1008PubMedCrossRef Bart BA, Shaw LK, McCants CB Jr, Fortin DF, Lee KL, Califf RM, O’Connor CM (1997) Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol 30:1002–1008PubMedCrossRef
14.
Zurück zum Zitat Felker GM, Shaw LK, O’Connor CM (2002) A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol 39:210–218PubMedCrossRef Felker GM, Shaw LK, O’Connor CM (2002) A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol 39:210–218PubMedCrossRef
15.
Zurück zum Zitat Ndrepepa G, Tada T, Fusaro M, Cassese S, King L, Hadamitzky M, Haase HU, Schomig A, Kastrati A, Pache J (2012) Association of coronary atherosclerotic burden with clinical presentation and prognosis in patients with stable and unstable coronary artery disease. Clin Res Cardiol 101:1003–1011PubMedCrossRef Ndrepepa G, Tada T, Fusaro M, Cassese S, King L, Hadamitzky M, Haase HU, Schomig A, Kastrati A, Pache J (2012) Association of coronary atherosclerotic burden with clinical presentation and prognosis in patients with stable and unstable coronary artery disease. Clin Res Cardiol 101:1003–1011PubMedCrossRef
16.
Zurück zum Zitat Remme WJ, Swedberg K (2002) Comprehensive guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur J Heart Fail 4:11–22PubMedCrossRef Remme WJ, Swedberg K (2002) Comprehensive guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur J Heart Fail 4:11–22PubMedCrossRef
17.
Zurück zum Zitat Authors/Task Force M, McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Guidelines ESCCfP, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Document R, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14:803–869 Authors/Task Force M, McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Guidelines ESCCfP, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Document R, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14:803–869
18.
Zurück zum Zitat Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, Vahanian A, Camm J, De Caterina R, Dean V, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29:2388–2442PubMedCrossRef Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, Vahanian A, Camm J, De Caterina R, Dean V, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29:2388–2442PubMedCrossRef
19.
Zurück zum Zitat Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW (2009) 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119:e391–e479PubMedCrossRef Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW (2009) 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119:e391–e479PubMedCrossRef
20.
Zurück zum Zitat Wynne J, Braunwald E (2001) The cardiomyopathies and myocarditides. In: Braunwald E, Zipes DP, Libby P (eds) Heart disease. Saunders, Philadelphia, pp 1751–1806 Wynne J, Braunwald E (2001) The cardiomyopathies and myocarditides. In: Braunwald E, Zipes DP, Libby P (eds) Heart disease. Saunders, Philadelphia, pp 1751–1806
21.
Zurück zum Zitat Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470PubMedCrossRef Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470PubMedCrossRef
22.
Zurück zum Zitat Lin D, Wei L, Ying Z (1993) Checking the Cox model with cumulative sums of martingale-based residuals. Biometrika 80:557–572CrossRef Lin D, Wei L, Ying Z (1993) Checking the Cox model with cumulative sums of martingale-based residuals. Biometrika 80:557–572CrossRef
23.
Zurück zum Zitat Therneau TM, Grambsch PM, Fleming TR (1990) Martingale-based residuals for survival models. Biometrika 77:147–160CrossRef Therneau TM, Grambsch PM, Fleming TR (1990) Martingale-based residuals for survival models. Biometrika 77:147–160CrossRef
24.
Zurück zum Zitat LTD STP Sample Size for Survival Rates Program. In: Chang A (ed) StatsToDo LTD STP Sample Size for Survival Rates Program. In: Chang A (ed) StatsToDo
25.
Zurück zum Zitat Cleland JG, Thygesen K, Uretsky BF, Armstrong P, Horowitz JD, Massie B, Packer M, Poole-Wilson PA, Ryden L (2001) Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study. Eur Heart J 22:1601–1612PubMedCrossRef Cleland JG, Thygesen K, Uretsky BF, Armstrong P, Horowitz JD, Massie B, Packer M, Poole-Wilson PA, Ryden L (2001) Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study. Eur Heart J 22:1601–1612PubMedCrossRef
26.
Zurück zum Zitat Yusuf S, Pepine CJ, Garces C, Pouleur H, Salem D, Kostis J, Benedict C, Rousseau M, Bourassa M, Pitt B (1992) Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 340:1173–1178PubMedCrossRef Yusuf S, Pepine CJ, Garces C, Pouleur H, Salem D, Kostis J, Benedict C, Rousseau M, Bourassa M, Pitt B (1992) Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 340:1173–1178PubMedCrossRef
27.
Zurück zum Zitat Cooke GE, Eaton GM, Whitby G, Kennedy RA, Binkley PF, Moeschberger ML, Leier CV (2000) Plasma atherogenic markers in congestive heart failure and posttransplant (heart) patients. J Am Coll Cardiol 36:509–516PubMedCrossRef Cooke GE, Eaton GM, Whitby G, Kennedy RA, Binkley PF, Moeschberger ML, Leier CV (2000) Plasma atherogenic markers in congestive heart failure and posttransplant (heart) patients. J Am Coll Cardiol 36:509–516PubMedCrossRef
28.
Zurück zum Zitat Franciosa JA, Wilen M, Ziesche S, Cohn JN (1983) Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 51:831–836PubMedCrossRef Franciosa JA, Wilen M, Ziesche S, Cohn JN (1983) Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 51:831–836PubMedCrossRef
29.
Zurück zum Zitat Kelly TL, Cremo R, Nielsen C, Shabetai R (1990) Prediction of outcome in late-stage cardiomyopathy. Am Heart J 119:1111–1121PubMedCrossRef Kelly TL, Cremo R, Nielsen C, Shabetai R (1990) Prediction of outcome in late-stage cardiomyopathy. Am Heart J 119:1111–1121PubMedCrossRef
30.
Zurück zum Zitat Pereira VF, de Carvalho Frimm C, Rodrigues AC, Curi M (2010) Coronary reserve impairment prevents the improvement of left ventricular dysfunction and adversely affects the long-term outcome of patients with hypertensive dilated cardiomyopathy. J Am Soc Hypertens 4:14–21PubMedCrossRef Pereira VF, de Carvalho Frimm C, Rodrigues AC, Curi M (2010) Coronary reserve impairment prevents the improvement of left ventricular dysfunction and adversely affects the long-term outcome of patients with hypertensive dilated cardiomyopathy. J Am Soc Hypertens 4:14–21PubMedCrossRef
31.
Zurück zum Zitat de Jong RM, Tio RA, van der Harst P, Voors AA, Koning PM, Zeebregts CJ, van Veldhuisen DJ, Dierckx RA, Slart RH (2009) Ischemic patterns assessed by positron emission tomography predict adverse outcome in patients with idiopathic dilated cardiomyopathy. J Nucl Cardiol 16:769–774PubMedCrossRef de Jong RM, Tio RA, van der Harst P, Voors AA, Koning PM, Zeebregts CJ, van Veldhuisen DJ, Dierckx RA, Slart RH (2009) Ischemic patterns assessed by positron emission tomography predict adverse outcome in patients with idiopathic dilated cardiomyopathy. J Nucl Cardiol 16:769–774PubMedCrossRef
32.
Zurück zum Zitat de Groote P, Lamblin N, Mouquet F, Bauters C (2008) No gender survival difference in a population of patients with chronic heart failure related to left ventricular systolic dysfunction and receiving optimal medical therapy. Arch Cardiovasc Dis 101:242–248PubMedCrossRef de Groote P, Lamblin N, Mouquet F, Bauters C (2008) No gender survival difference in a population of patients with chronic heart failure related to left ventricular systolic dysfunction and receiving optimal medical therapy. Arch Cardiovasc Dis 101:242–248PubMedCrossRef
33.
Zurück zum Zitat Frankenstein L, Remppis A, Fluegel A, Doesch A, Katus HA, Senges J, Zugck C (2010) The association between long-term longitudinal trends in guideline adherence and mortality in relation to age and sex. Eur J Heart Fail 12:574–580PubMedCrossRef Frankenstein L, Remppis A, Fluegel A, Doesch A, Katus HA, Senges J, Zugck C (2010) The association between long-term longitudinal trends in guideline adherence and mortality in relation to age and sex. Eur J Heart Fail 12:574–580PubMedCrossRef
34.
Zurück zum Zitat Lupon J, Urrutia A, Gonzalez B, Diez C, Altimir S, Albaladejo C, Pascual T, Rey-Joly C, Valle V (2007) Does heart failure therapy differ according to patient sex? Clin Cardiol 30:301–305PubMedCrossRef Lupon J, Urrutia A, Gonzalez B, Diez C, Altimir S, Albaladejo C, Pascual T, Rey-Joly C, Valle V (2007) Does heart failure therapy differ according to patient sex? Clin Cardiol 30:301–305PubMedCrossRef
35.
Zurück zum Zitat Franke J, Zugck C, Wolter JS, Frankenstein L, Hochadel M, Ehlermann P, Winkler R, Nelles M, Zahn R, Katus HA, Senges J (2012) A decade of developments in chronic heart failure treatment: a comparison of therapy and outcome in a secondary and tertiary hospital setting. Clin Res Cardiol 101:1–10PubMedCrossRef Franke J, Zugck C, Wolter JS, Frankenstein L, Hochadel M, Ehlermann P, Winkler R, Nelles M, Zahn R, Katus HA, Senges J (2012) A decade of developments in chronic heart failure treatment: a comparison of therapy and outcome in a secondary and tertiary hospital setting. Clin Res Cardiol 101:1–10PubMedCrossRef
36.
Zurück zum Zitat Rihal CS, Raco DL, Gersh BJ, Yusuf S (2003) Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: review of the evidence and methodological considerations. Circulation 108:2439–2445PubMedCrossRef Rihal CS, Raco DL, Gersh BJ, Yusuf S (2003) Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: review of the evidence and methodological considerations. Circulation 108:2439–2445PubMedCrossRef
37.
Zurück zum Zitat Weintraub WS, Spertus JA, Kolm P, Maron DJ, Zhang Z, Jurkovitz C, Zhang W, Hartigan PM, Lewis C, Veledar E, Bowen J, Dunbar SB, Deaton C, Kaufman S, O’Rourke RA, Goeree R, Barnett PG, Teo KK, Boden WE, Group CTR, Mancini GB (2008) Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med 359:677–687 Weintraub WS, Spertus JA, Kolm P, Maron DJ, Zhang Z, Jurkovitz C, Zhang W, Hartigan PM, Lewis C, Veledar E, Bowen J, Dunbar SB, Deaton C, Kaufman S, O’Rourke RA, Goeree R, Barnett PG, Teo KK, Boden WE, Group CTR, Mancini GB (2008) Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med 359:677–687
Metadaten
Titel
Clinical characteristics, morbidity, and prognostic value of concomitant coronary artery disease in idiopathic dilated cardiomyopathy
verfasst von
Lutz Frankenstein
Henrik Hees
Tobias Taeger
Hanna Froehlich
Andreas Dösch
Rita Cebola
Christian Zugck
Hugo A. Katus
Publikationsdatum
01.10.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 10/2013
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-013-0589-7

Weitere Artikel der Ausgabe 10/2013

Clinical Research in Cardiology 10/2013 Zur Ausgabe

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.